Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

Kimberly-Clark Sticks to 2026 Outlook, Beats Sales Estimates

Kimberly-Clark kept its annual forecast intact and beat first-quarter sales estimates on Tuesday, as the company expects to close its $40 billion acquisition of Tylenol and Neutrogena in the second half of 2026.
Kimberly-Clark
The Kleenex-owner beat sales estimates in the first quarter of 2026. (Kimberly-Clark)

Kimberly-Clark kept its annual forecast intact and beat first-quarter sales estimates on Tuesday, as lower prices at the Kleenex tissue maker helped draw budget-strained consumers amid persisting geopolitical and macroeconomic uncertainties.

Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.

In This Article
Topics

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Beauty
Analysis and advice on the fast-evolving beauty business.

Can the ‘MAC of Italy’ Make It in America?

European cosmetics giant Kiko Milano has racked up over $1 billion in sales with storefronts across the globe from Chile to India. Until now, success in the hyper-competitive US market has been more elusive, however.


view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.
VIEW MORE
Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON